Dover has entered into a definitive agreement to acquire Malema Engineering Corp, a US designer and producer of high-precision, mission-critical flow-measurement and control instruments for the biopharmaceutical, semiconductor and industrial sectors.
Malema’s products will increase Dover’s biopharma single-use production offering, which already contains Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in เครื่องมือที่ใช้ในการวัดความดัน , Florida, and with services in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in income through the full year 2022.
When the deal closes, Malema will turn into a half of the PSG business unit within Dover’s Pumps & Process Solutions phase.
“We see a tremendous long-term development alternative within the bioprocessing industry driven by a powerful and growing pipeline of efficient novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the growing adoption of extra efficient single-use production processes helps a strong outlook for our offerings of single-use components to end-customers. We believe that pairing Malema’s technology with our current portfolio of single-use pumps for biopharma processing will tremendously improve the accuracy and worth proposition of our options to our clients.”
“We are methodically constructing out our biopharma platform through proactive capacity additions, new product improvement, and opportunistic acquisitions of highly-attractive niche element technologies,” mentioned Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing expertise and additional strengthens our sensor portfolio with new proprietary technology. In addition to enticing biopharma functions, we count on sturdy progress in the semiconductor space on the capacity growth and re-shoring tailwinds.”
Share